Lv71
5000 积分 2021-05-11 加入
Targeting CD38 with bispecific antibody XmAb 18968 in patients with relapsed/refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia
1个月前
已完结
Teclistamab in Relapsed or Refractory Multiple Myeloma
2个月前
已完结
GPRC5D as a novel immunotherapeutic target in multiple myeloma
3个月前
已完结
BCMA biology and therapeutic targeting in multiple myeloma: From ligand signaling to antigen escape
3个月前
已完结
An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors
5个月前
已完结
Antibody engineering
5个月前
已完结
Yeast Display and Competitive FACS: Powerful Tools for the Selection of Rare Clones from an scFv Library
5个月前
已完结
Development of Bispecific Antibody Targeting Human IL-17A and IL-6
6个月前
已完结
Structural and functional insights into CD3 bispecific antibodies targeting DLL3 in cancer immunotherapy
7个月前
已完结
Characterization of an anti-STEAP1 T-Cell Dependent Bispecific Antibody for the Treatment of Prostate Cancer and Associated Toxicity in Cynomolgus Monkeys
8个月前
已完结
皖公网安备34019202002308
